SCHEDULE: Davion Healthcare Shareholder Consolidation

Jack Harry Kaye consolidates over 10.2 million Davion Healthcare shares into his personal name, maintaining his 41.08% stake.

Summary

• This filing is an amendment to a previous Schedule 13D, detailing a change in how Jack Harry Kaye holds his shares in Davion Healthcare plc.
• On August 11, 2026, Rallinson Corp transferred 1,245,000 ordinary shares and Rallinson Ltd transferred 3,860,530 ordinary shares to Jack Harry Kaye.
• These transfers were for no consideration and resulted in the consolidation of shares previously held indirectly by Mr. Kaye through these entities into his direct personal ownership.
• Mr. Kaye remains the ultimate beneficial owner of all 10,268,948 ordinary shares, representing approximately 41.08% of the Issuer's outstanding ordinary shares.
• Rallinson Corp and Rallinson Ltd no longer beneficially own any shares in Davion Healthcare plc as a result of these transfers.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reflecting an internal restructuring of share ownership rather than a change in overall control or financial performance.

Positives

• Jack Harry Kaye maintains his significant ownership stake of 41.08% in Davion Healthcare plc.
• The consolidation of shares into direct personal ownership by Mr. Kaye may simplify reporting and governance for his holdings.
• The filing confirms that Mr. Kaye's aggregate beneficial ownership has not changed, indicating no dilution or acquisition of new shares from third parties.

Negatives

• The filing does not provide any new financial performance data or strategic updates for Davion Healthcare plc.
• The transfer of shares between entities controlled by the same individual does not inherently signal operational improvements or growth.

Risks

• While not explicitly stated as a risk in this filing, any significant change in Mr. Kaye's direct holdings or future intentions could impact the company's strategic direction.
• The concentration of over 41% of shares in a single individual could pose governance risks if not balanced by a strong independent board and shareholder rights.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the future performance or strategy of Davion Healthcare plc. It solely addresses a change in shareholding structure.

Management Comments

• Mr. Kaye was the ultimate beneficial owner of such Ordinary Shares immediately before the transfers and remained the beneficial owner immediately following the transfers.
• The transfers were undertaken solely for the purpose of consolidating Mr. Kaye's holdings of Ordinary Shares into his personal name and converting the manner in which such shares are held from indirect ownership through Rallinson Corp and Rallinson Ltd to direct ownership by Mr. Kaye.

Industry Context

StockSavvy.ai notes that while this filing is a routine disclosure of beneficial ownership changes under SEC regulations, significant shifts in major shareholder holdings, even if internal, can sometimes precede strategic actions or signal confidence (or lack thereof) in a company's prospects within the healthcare sector.

Related Party Transactions

• Transfer of 1,245,000 ordinary shares from Rallinson Corp to Jack Harry Kaye for no consideration.
• Transfer of 3,860,530 ordinary shares from Rallinson Ltd to Jack Harry Kaye for no consideration.
• Jack Harry Kaye is the sole director, sole shareholder, and ultimate beneficial owner of both Rallinson Corp and Rallinson Ltd.

Stakeholder Impact

• Shareholders: No immediate change in overall beneficial ownership or control, but direct holding by Mr. Kaye may simplify future communications or actions.
• Creditors/Suppliers: No direct impact indicated by this filing.
• Employees: No direct impact indicated by this filing.

Next Steps

• Rallinson Corp and Rallinson Ltd will cease to have an ongoing reporting obligation under Section 13(d) unless they subsequently become beneficial owners again.
• Future filings will reflect Jack Harry Kaye's direct ownership of 10,268,948 ordinary shares.

Key Dates

Keywords

Davion Healthcare, Schedule 13D, Shareholder, Beneficial Ownership, Ordinary Shares, Corporate Restructuring, Jack Harry Kaye